SFR-9X-012-2

N/A

Report date: 2025/01/26 17:51:39

Base Information

Drug NameSFR-9X-012-2
Drug Alias NameSFR-9X-012-2
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulatorsVascular endothelial growth factor receptor stimulants
TargetsEpidermal growth factor receptor erbB1Vascular endothelial growth factor receptor
Therapy Area/IndicationsCorneal Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFortunerock (China) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFortunerock (China) Ltd
Inactive CompaniesN/A
Active IndicationsCorneal Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A